✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹18 Cr.
P/E
0.00

Key Ratios

Market cap
Market cap
18.00 Cr
PE
PE
-
Prom Holding
Prom Holding
23.13 %
ROE (%)
ROE (%)
-9.92
ROCE (%)
ROCE (%)
-13.46
Div Yield (%)
Div Yield (%)
-
Sales
Sales
1.91 Cr
OPM (%)
OPM (%)
-52.59 %
Debt to Equity
Debt to Equity
-0.54

About

Venmax Drugs and Pharmaceuticals Limited engages in the manufacture and sale of bulk drugs int… Read more
Low
6
52W Range
High
37
  • Venmax Drugs&Pharma
  • Chemo Pharma Labs
  • Link Pharma Chem

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Venmax Drugs And Pharmaceuticals Ltd. Business

Venmax Drugs and Pharmaceuticals Limited engages in the manufacture and sale of bulk drugs intermediates primarily in India. It primarily offers trityl chloride. The company, formerly known as Yenkey Drugs and Pharmaceuticals Limited, was incorporated in 1988 and is based in Hyderabad, India.

Venmax Drugs&Pharma major competitors are Saroja Pharma Ind, Link Pharma Chem, Chemo Pharma Labs, Norris Medicines, Emmessar Biotech&Nut, Ishita Drugs & Inds., Zenith Health Care.
Market Cap of Venmax Drugs&Pharma is ₹18 Crs.
While the median market cap of its peers are ₹19 Crs.

Venmax Drugs&Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Venmax Drugs&Pharma is -112.1 and is ranked 8 out of its 8 competitors.

Company Filing

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material